Lucid’s magic touch wins them two coveted trophies at the PMEA

Lucid’s pledge to improve patient outcomes through pioneering medical education programmes has been recognised at the PMEA this year. The company won its first award of the night in the category “Excellence in Rare Diseases and Orphan Drugs” for the EIDON programme, which focuses on establishing specialist care for patients with hidradenitis suppurativa. The second award went to the OptiMiSe team in the category “Excellence in Healthcare Professional Education and Support” for their multi-channel learning platform. OptiMiSe is aimed at multiple sclerosis specialist nurses, and helps them overcome behavioural barriers to improve MS management.

Jan Steele (Lucid co-founder and COO) commented: “2017 has been a magical year for everybody at Lucid. We feel privileged to work with clients who share the same passion and ambition to make a difference. It’s wonderful to see that our work, and our commitment to transforming the lives of those we touch, has been recognised at the PMEA.”

Recent posts
We transform lives. Always. Get in touch to find out more.